Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of Fospropofol Disodium in Anesthesia Induction and Maintenance
NCT06344325Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- May 2024
- Primary completion
- Feb 2025
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fospropofol disodium (3 arms), sponsored by Tongji Hospital. Primary endpoint: Sedation score at 1 day. Started May 2024; status: completed.
02
Drugs
fospropofol disodium
Beyond the preview
Go deeper on NCT06344325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06344325.